Mucus and its gel-forming glycoprotein component, mucin, are thought to protect the gastrointestinal tract from enteric pathogens by inhibiting their attachment to enterocytes. In this study, we investigated interactions between Yersinia enterocolitica (isogenic strains of virulent and nonvirulent organisms) and crude mucus, highly purffied mucin, and brush border membranes (BBMs) The mammalian gastrointestinal tract is lined with a continuous layer of mucus which is thought to form a physical barrier between the underlying mucosa and potentially harmful substances in the lumen and to act as a lubricant preventing physical injury of the mucosal surface (5, 33). The principal component of mucus is a complex, highmolecular-weight (>2 x 106) glycoprotein (mucin) that is responsible for the characteristic visco-elastic properties of the secretion (33). It has been suggested that mucus or mucin itself may protect against enteric pathogens by entrapping them in the gut lumen, inhibiting their attachment to epithelial membranes, and assisting in their removal from the body. This suggestion is based largely on the observation that pathogenic organisms (16, 20, 28) and their secretory products (particularly enterotoxins [9, 31] ) cause a marked increase in mucin secretion.
The mammalian gastrointestinal tract is lined with a continuous layer of mucus which is thought to form a physical barrier between the underlying mucosa and potentially harmful substances in the lumen and to act as a lubricant preventing physical injury of the mucosal surface (5, 33) . The principal component of mucus is a complex, highmolecular-weight (>2 x 106) glycoprotein (mucin) that is responsible for the characteristic visco-elastic properties of the secretion (33) . It has been suggested that mucus or mucin itself may protect against enteric pathogens by entrapping them in the gut lumen, inhibiting their attachment to epithelial membranes, and assisting in their removal from the body. This suggestion is based largely on the observation that pathogenic organisms (16, 20, 28) and their secretory products (particularly enterotoxins [9, 31] ) cause a marked increase in mucin secretion.
Recently, we investigated the effects of Yersinia enterocolitica, a common cause of infectious diarrhea in humans, on the production of intestinal and colonic mucin in the rabbit (25) . Infection of rabbits with Y. enterocolitica is known to result in disease that resembles human yersiniosis both clinically and morphologically (34, 36) . While synthesis and secretion of mucin were increased throughout the intestinal tract by day 6 postinfection, the greatest changes occurred in the distal small intestine and the proximal colon, where the morphologic impact of the disease is most severe (34, 36) .
The mechanism by which Y. enterocolitica colonizes the gut is unknown. In contrast to nonpathogenic environmental isolates, pathogenic strains of Y. enterocolitica contain a 42-* Corresponding author.
to 50-megadalton plasmid (10) . While the virulence-associated plasmid is required for the pathogenesis of disease, its precise role is not clear. The plasmid codes for 16 to 20 proteins (38, 40) . A number of these are located on the outer membrane of the bacterium and form fibrillae (14, 38) that significantly increase the surface charge and hydrophobicity of the organism (17, 39) . Among the virulent properties of Y. enterocolitica is the ability to adhere to, invade, and detach a variety of epithelial cells (HeLa, Henle, HEp-2, and Vero cells) in tissue culture (11, 35, 37, 39, 41, 42) . However, the virulence plasmid may not be responsible for tissue invasion, since this property is restricted to certain serotypes and biotypes and strains lacking the plasmid can also invade tissue culture cells (11, 35, 37, 39, 41) . Recently, two chromosomal loci, inv and ail, were identified in a virulent strain of Y. enterocolitica which individually conferred an invasive phenotype on noninvasive Escherichia coli HB101 (29) . The inv gene is present in all strains of Y. enterocolitica, but the ail gene was only found in pathogenic strains that invaded tissue culture cells (30) . Although invasion appears to be controlled largely by the presence of particular chromosomal genes, a number of studies have suggested that the adhesive properties of Y. enterocolitica may be primarily determined by the virulence plasmid (11, 39, 41 (22) , except in the case of mucus from the proximal colon, which was adjusted to a final concentration of 3 mg of protein per ml. The concentration of mucin in these crude mucus preparations was measured by a highly specific enzyme-linked immunoassay (24) .
Mucin was purified in the presence of proteolytic inhibitors from the upper, mid-, and distal small intestine and the proximal colon of the rabbit as described previously (24) . Mucosal scrapings were homogenized, and mucin was isolated by equilibrium density gradient centrifugation in CsCl (twice) followed by gel filtration on Sepharose 2B. Completely purified mucin, harvested from the void volume fractions of the column, was dialyzed and stored lyophilized at -80°C. The chemical compositions of the four rabbit mucins and their polymeric structures were documented in earlier studies (24) . In addition, human and rat intestinal mucins were isolated by the same procedure from the entire length of the small bowel. Human mucin was prepared from tissue obtained 4.5 h postmortem from a patient (H35) with no history of gastrointestinal disease (23) . On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, all mucin preparations produced a diffuse, silver-staining band in the stacking gel; no other bands were observed in the separating gel, indicating the absence of noncovalently bound contaminating protein (23, 24) . The failure to detect DNA (<2 pxg of glycoprotein per ml), mannose, glucose, or uronic acid (by gas-liquid chromatography) confirmed the purity of all mucin preparations (23, 24) . For (21, 26) and were then washed and suspended. Control cultures were incubated concurrently but without pronase. Control and digested bacteria were examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis before and after pronase treatment as described by Lian and Pai (21) . Viable counts of bacteria were obtained by plating 0.1-ml samples of serial 10-fold dilutions onto salmonellashigella agar. To determine the radioactivity incorporated per bacterium, a 50-,ul sample of the final suspension was counted by scintillation spectrometry.
Binding assay. The method used to assess binding of Y. enterocolitica to rabbit intestinal BBM, mucus, and mucin preparations was a modification of that described by Laux et al. (19) . Duplicate assays were performed in 96-well roundbottomed polystyrene tissue culture plates (Flow Laboratories, Inc., McLean, Va.). Each substrate (50 ,ul) was added to the wells of the microtiter plate and incubated overnight at 4°C. Unbound material was removed by three washes with PBS. Residual binding sites were blocked by addition of 200 pAl of skim milk (20 mg/ml in PBS) and incubation at room temperature for 2 h. Unbound material was again removed by three washes with PBS. Serial dilutions of freshly prepared radiolabeled bacteria (50 ,ul) were added to the wells and incubated for 2 h at 25°C. Preliminary experiments indicated that 2 h was sufficient time to achieve maximum binding of Y. enterocolitica strains to BBM, mucus, or mucin. After thorough washing with PBS (four times), plates were drained dry and wells were cut out and counted directly by scintillation spectrometry. Counting efficiency and quenching were unaffected by the presence of the well and were constant among experiments. The number of Y. enterocolitica bound to each well was calculated based on the specific activity of the bacterial preparation used for that particular experiment. Control wells containing skim milk but no BBM, mucus, or mucin were included in each dard assay conditions, but no bacteria were added. In all cases, essentially the same amount of protein (-8 ,ug) bound to the wells. Compared with virulent organisms, nonvirulent Y. enterocolitica P-showed significantly lower binding to all BBM preparations (P < 0.001) (Fig. 1) . When Y. enterocolitica P+ was cultured at 25°C, a condition which inhibits the expression of plasmid-encoded proteins, binding to BBM preparations was markedly reduced (Fig. 1) . Adherence of Y. enterocolitica P+(25°C) was essentially the same as that of Y. enterocolitica P-, and in both cases maximum binding was similar in the four intestinal regions.
Adherence of Y. enterocolitica P+ and P-to crude mucus and purified mucin preparations from the small intestine and proximal colon is shown in Fig. 2 (Fig. 3) . In contrast, adherence of Y. enterocolitica P-and P+(250C) to mucin accounted for the majority of the binding to mucus in all regions of the gut.
To investigate whether outer membrane proteins were involved in binding, bacteria were pretreated with pronase under conditions known to degrade plasmid-mediated cell surface proteins (21, 26) (Fig.  4) . (It should be noted that binding of control [nondigested] bacteria in these experiments did not reach the maximum levels shown in Fig. 1 since only -4 x 108 organisms were added to the wells.) Proteolysis had essentially no effect on adherence of Y. enterocolitica P-or P+(25°C) to BBMs; the reduction in binding after digestion was <10%. To confirm the effects of pronase on membrane proteins, bacteria were examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis before and after digestion. On Coomassie (Fig. 5) . Increasing concentrations of mucus or mucin increased the degree of inhibition. Binding of Y. enterocolitica P+ to BBMs could be inhibited with as little as 1 ,ug of mucus (protein) and 2 ,ug of mucin; at levels below this, there was no detectable inhibition. The inhibitory effect of crude mucus was greater than could be explained by its mucin content. Inhibition with crude mucus containing 4 pug of mucin (Fig. 5, upper panel) was significantly greater (P < 0.05) than that seen with 5 pug of purified mucin (Fig. 5, lower panel) . Since binding of Y. Binding of Y. enterocolitica to human and rat intestinal mucin. To assess whether binding of Y. enterocolitica to intestinal mucin was specific to the rabbit, we investigated adherence of the organism to purified intestinal mucins from humans and rats (Fig. 6 ). Y. enterocolitica P+ showed saturable binding to human intestinal mucin, but the slope of the binding curve and maximum adherence were considerably higher than those observed to mucin from the rabbit small or large intestine (P < 0.001). In contrast, binding of Y.
enterocolitica P+ to rat intestinal mucin was significantly lower than that to rabbit intestinal mucins (P < 0.02). As in the case of rabbit mucins, nonvirulent Y. enterocolitica Por P+(25°C) showed limited adherence to either human or rat intestinal mucin compared with virulent Y. enterocolitica P+.
DISCUSSION
It has often been suggested that the mucus layer covering the epithelial surface may protect against colonization of the intestinal tract by enteric pathogens by inhibiting their attachment to enterocytes, an essential early step in the processes that lead to disease (1) . To investigate this hypothesis, the present studies were designed with three objectives in mind: (i) to examine whether Y. enterocolitica, an enteroinvasive organism, was capable of binding to mucus, mucin (the gel-forming glycoprotein component of mucus), and BBMs from the rabbit intestine; (ii) to establish whether binding was greater in those regions of the gut most affected during yersiniosis, namely, the distal small intestine and the proximal colon (34, 36) ; and (iii) to determine whether mucus and mucin prevented adherence of the organisms to BBMs.
The virulent strain of Y. enterocolitica used in these experiments, P+, showed saturable binding to mucus, mucin, and BBMs isolated from the upper, mid-, and distal small intestine and the proximal colon of rabbits, although adherence to BBMs was appreciably greater than that to mucus and mucin. Of particular interest was the observation that maximal binding of Y. enterocolitica P+ was higher to BBMs from the distal small intestine and the proximal colon than to those from the upper and mid-small intestine. These findings suggest that the number of receptors for the organism is greater in cell membranes in the ileo-cecal regions of the gut. It is possible that enhanced binding of Y. enterocolitica P+ to BBMs may at least in part explain why the organism localizes to, and causes the most damage in, the distal small intestine and the proximal colon. Similar results were obtained in previous studies on rabbit diarrheagenic E. coli RDEC-1, when adherence was found to be significantly greater to rabbit ileal BBMs than tojejunal BBMs (3) . Again, the in vitro adherence of RDEC-1 to host cell membranes correlated positively with in vivo infectivity and colonization of the intestinal tract.
Binding of Y. enterocolitica P+ to BBMs could not be attributed to the presence of mucin since our membrane preparations were essentially devoid of mucin. Similarly, it is unlikely that bacterial binding to mucin was due to the presence of BBM components since our mucins were highly purified. (6) . Vibrio cholerae 01 (43) , Campylobacter jejuni (27) , the fungal pathogen Candida albicans (15) , and the protozoan Entamoeba histolytica (2) have all been reported to associate with mucus. Most of the above studies assessed adherence by using crude mucus preparations or partially purified mucins, isolated by gel filtration, which does not completely remove noncovalently attached material from the mucin. Therefore, it is not clear from these studies whether the organisms truly interact with the mucin component of mucus. In two cases, however, RDEC-1 (6) and Entamoeba histolytica (2) , specific binding of the organism to thoroughly purified mucin was demonstrated. As in the present study with Y. enterocolitica, attachment of RDEC-1 and Entamoeba histolytica to rabbit intestinal BBMs and rat colonic epithelial cells, respectively, was significantly inhibited by the presence of homologous, highly purified mucin (2, 6 enterocolitica to BBMs, mucus, and mucin. While mucus and mucin may protect the intestinal mucosa against enteric pathogens, it is also possible that the ability to bind to mucus components may actually facilitate colonization of the intestinal tract by immobilizing the bacteria in the gel. However, the mucus gel is continually eroded by enzymes (some of which are produced by the bacteria themselves) and by mechanical forces (passage of digesta). This erosion is likely to wash adherent bacteria into the lumen of the digestive tract. Thus, to achieve successful colonization, the replication rate of bacteria attached to mucus must be equal to the rate of erosion of the mucus layer itself. In all likelihood, the stability of the indigenous bacterial population of the gut, which appears to be limited largely to the mucus gel layer (5) , is maintained as a result of this balance between replication and erosion. Since many enteric pathogens require access to the epithelium to mediate disease, the organism's virulence factors must overcome the host's defense system; that is, the pathogen must be able to resist turnover with mucus and cross the mucus gel barrier to the epithelium. The mechanisms of binding of Y. enterocolitica to epithelial membranes and mucin, including the nature of the bacterial adhesin and the mucin-epithelial receptor, and the means by which the organism traverses the mucus gel require further investigation.
